dipyridamole has been researched along with Cardiac Output, Low in 7 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Cardiac Output, Low: A state of subnormal or depressed cardiac output at rest or during stress. It is a characteristic of CARDIOVASCULAR DISEASES, including congenital, valvular, rheumatic, hypertensive, coronary, and cardiomyopathic. The serious form of low cardiac output is characterized by marked reduction in STROKE VOLUME, and systemic vasoconstriction resulting in cold, pale, and sometimes cyanotic extremities.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Absolute regional MBF (milliliters per minute per gram) was measured by positron emission tomography and 13N-ammonia in resting conditions, during pacing-induced tachycardia, and after dipyridamole infusion (0." | 7.69 | Myocardial blood flow response to pacing tachycardia and to dipyridamole infusion in patients with dilated cardiomyopathy without overt heart failure. A quantitative assessment by positron emission tomography. ( Gallopin, M; Giorgetti, A; Lunardi, M; Michelassi, C; Neglia, D; Parodi, O; Pelosi, G; Pratali, L; Salvadori, P; Sambuceti, G, 1995) |
| "Absolute regional MBF (milliliters per minute per gram) was measured by positron emission tomography and 13N-ammonia in resting conditions, during pacing-induced tachycardia, and after dipyridamole infusion (0." | 3.69 | Myocardial blood flow response to pacing tachycardia and to dipyridamole infusion in patients with dilated cardiomyopathy without overt heart failure. A quantitative assessment by positron emission tomography. ( Gallopin, M; Giorgetti, A; Lunardi, M; Michelassi, C; Neglia, D; Parodi, O; Pelosi, G; Pratali, L; Salvadori, P; Sambuceti, G, 1995) |
| "Adenosine is known to be an endogenous cardioprotective substance." | 2.69 | Elevation of plasma adenosine levels may attenuate the severity of chronic heart failure. ( Funaya, H; Hori, M; Kitakaze, M; Komamura, K; Koretsune, Y; Kuzuya, T; Minamino, T; Node, K, 1998) |
| "In a Cox model, mitral insufficiency (hazard ratio [HR] 1." | 1.34 | The independent prognostic value of contractile and coronary flow reserve determined by dipyridamole stress echocardiography in patients with idiopathic dilated cardiomyopathy. ( Galderisi, M; Gherardi, S; Picano, E; Rigo, F; Sicari, R, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (71.43) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ciampi, Q | 1 |
| Cortigiani, L | 1 |
| Pratali, L | 2 |
| Rigo, F | 2 |
| Villari, B | 1 |
| Picano, E | 2 |
| Sicari, R | 2 |
| Gherardi, S | 1 |
| Galderisi, M | 1 |
| Neglia, D | 1 |
| Parodi, O | 1 |
| Gallopin, M | 1 |
| Sambuceti, G | 1 |
| Giorgetti, A | 1 |
| Salvadori, P | 1 |
| Michelassi, C | 1 |
| Lunardi, M | 1 |
| Pelosi, G | 1 |
| Kontos, MC | 1 |
| Brath, LK | 1 |
| Akosah, KO | 1 |
| Mohanty, PK | 1 |
| McClellan, JR | 1 |
| Travin, MI | 1 |
| Herman, SD | 1 |
| Baron, JI | 1 |
| Golub, RJ | 1 |
| Gallagher, JJ | 1 |
| Waters, D | 1 |
| Heller, GV | 1 |
| Pierard, LA | 1 |
| Hoffer, EP | 1 |
| Kitakaze, M | 1 |
| Minamino, T | 1 |
| Node, K | 1 |
| Koretsune, Y | 1 |
| Komamura, K | 1 |
| Funaya, H | 1 |
| Kuzuya, T | 1 |
| Hori, M | 1 |
1 review available for dipyridamole and Cardiac Output, Low
| Article | Year |
|---|---|
Role of stress echocardiography in heart failure.
Topics: Cardiac Output, Low; Cardiotonic Agents; Dipyridamole; Dobutamine; Echocardiography, Doppler; Humans | 1998 |
1 trial available for dipyridamole and Cardiac Output, Low
| Article | Year |
|---|---|
Elevation of plasma adenosine levels may attenuate the severity of chronic heart failure.
Topics: Adenosine; Adult; Aged; Cardiac Output, Low; Chronic Disease; Dilazep; Dipyridamole; Humans; Middle | 1998 |
5 other studies available for dipyridamole and Cardiac Output, Low
| Article | Year |
|---|---|
Left Bundle Branch Block Negatively Affects Coronary Flow Velocity Reserve and Myocardial Contractile Reserve in Nonischemic Dilated Cardiomyopathy.
Topics: Blood Flow Velocity; Bundle-Branch Block; Cardiac Output, Low; Cardiomyopathy, Dilated; Coronary Ang | 2016 |
The independent prognostic value of contractile and coronary flow reserve determined by dipyridamole stress echocardiography in patients with idiopathic dilated cardiomyopathy.
Topics: Blood Flow Velocity; Bundle-Branch Block; Cardiac Output, Low; Cardiomyopathy, Dilated; Coronary Ang | 2007 |
Myocardial blood flow response to pacing tachycardia and to dipyridamole infusion in patients with dilated cardiomyopathy without overt heart failure. A quantitative assessment by positron emission tomography.
Topics: Adult; Aged; Cardiac Output, Low; Cardiac Pacing, Artificial; Cardiomyopathy, Dilated; Coronary Circ | 1995 |
Cardiac complications in noncardiac surgery: relative value of resting two-dimensional echocardiography and dipyridamole thallium imaging.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiac Output, Low; Coronary Artery Bypass; Coronary Disease; | 1996 |
Prognostic importance of scintigraphic left ventricular cavity dilation during intravenous dipyridamole technetium-99m sestamibi myocardial tomographic imaging in predicting coronary events.
Topics: Aged; Cardiac Output, Low; Coronary Circulation; Coronary Disease; Coronary Vessels; Death, Sudden, | 1997 |